Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT04056962

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus at different concentrations for superficial Kaposiform hemang…

China50 participantsStarted 2019-09-01

Treatment: Tacrolimus ointment

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

All recent trials (1 shown)